Ret 80 6082 Pill - purple round
Generic Name: selpercatinib
Pill with imprint Ret 80 6082 is Purple, Round and has been identified as Retevmo 80 mg. It is supplied by Eli Lilly and Company.
Retevmo is used in the treatment of Solid Tumors; Non-Small Cell Lung Cancer; Thyroid Cancer and belongs to the drug class multikinase inhibitors. Retevmo 80 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Ret 80 6082
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Ret 80 6082
- Strength
- 80 mg
- Color
- Purple (dark red-purple)
- Shape
- Round (film-coated)
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-6082
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
